Inovio Pharma (INO) Misses Q2 EPS by 3c
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)